@article{65297aa6ab2947a1a34121aa66cdffe4,
title = "Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic",
abstract = "We wish to bring your attention to the PsoPROTECT (Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of Covid-19 infecTion) and SECURE-AD (Surveillance Epidemiology of Coronavirus Under Research Exclusion-Atopic Dermatitis) registries; two urgent global initiatives that address an unmet need for delineating the determinants of COVID-19 outcomes in the common cutaneous immune-mediated inflammatory diseases (IMIDs) psoriasis and atopic dermatitis.",
author = "{The Secure-AD, PsoPROTECT study groups} and Mahil, {S. K.} and Yiu, {Z. Z.N.} and Mason, {K. J.} and N. Dand and B. Coker and D. Wall and G. Fletcher and A. Bosma and F. Capon and L. Iversen and Langan, {S. M.} and {Di Meglio}, P. and A. Musters and D. Prieto-Merino and T. Tsakok and Warren, {R. B.} and C. Flohr and P. Spuls and Griffiths, {C. E.M.} and J. Barker and Irvine, {A. D.} and Smith, {C. H.}",
year = "2020",
month = aug,
day = "1",
doi = "10.1111/bjd.19161",
language = "English",
volume = "183",
pages = "404--406",
journal = "British Journal of Dermatology",
issn = "0007-0963",
publisher = "John Wiley & Sons, Ltd (10.1111)",
number = "2",
}